AMRN – amarin corporation plc - american depositary shares (US:NASDAQ)

News

New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scientif
Amarin (AMRN) was upgraded by Zacks Research from "strong sell" to "hold".
Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology
Amarin Corp PLC (AMRN) Q4 2025 Earnings Call Highlights: Navigating Revenue Declines with ... [Yahoo! Finance]
Amarin Q4 Earnings Call Highlights [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com